Study guide

4.3 Revision Arthroplasty, Aseptic Loosening, Osteolysis & Implant Failure

ONCB Orthopaedic Nurse Certified ONC

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: ONC Exam Overview, Core Nursing Foundations & Neurovascular Assessment

1.1 ONC Certification Framework, Exam Blueprint & Test Strategies 1.2 Comprehensive Musculoskeletal Assessment & Diagnostic Modalities 1.3 Neurovascular Assessment & Orthopaedic Physical Examination Techniques

2 Chapter 2: Degenerative Joint Disease & Osteoarthritis Management

2.1 Osteoarthritis Pathophysiology, Risk Factors & Clinical Phenotypes 2.2 Conservative Management, Non-Pharmacologic & Pharmacologic Therapies for OA 2.3 Intra-Articular Injections & Joint Preservation Interventions

3 Chapter 3: Total Joint Arthroplasty — Hip & Knee

3.1 Total Hip Arthroplasty (THA): Surgical Approaches, Biomechanics & Component Types 3.2 Total Hip Arthroplasty: Postoperative Management, Hip Precautions & Dislocation Prevention 3.3 Total Knee Arthroplasty (TKA): Indications, Implant Designs & Surgical Techniques 3.4 Total Knee Arthroplasty: Postoperative Nursing Care, Pain Management & Early Mobilization

4 Chapter 4: Shoulder & Upper/Lower Extremity Arthroplasty and Revision Surgery

4.1 Total Shoulder Arthroplasty (TSA): Anatomic vs. Reverse TSA Indications & Precautions 4.2 Ankle, Elbow & Wrist Arthroplasty: Indications, Nursing Management & Functional Outcomes 4.3 Revision Arthroplasty, Aseptic Loosening, Osteolysis & Implant Failure

5 Chapter 5: Spinal Degenerative Disorders & Spinal Surgery

5.1 Cervical & Lumbar Spondylosis, Degenerative Disc Disease & Herniation 5.2 Spinal Stenosis, Neurogenic Claudication & Spondylolisthesis 5.3 Surgical Interventions: ACDF, Posterior Cervical Decompression, Lumbar Laminectomy & Fusion 5.4 Postoperative Spinal Nursing Care, CSF Leak Detection & Log-Rolling Protocols

6 Chapter 6: Orthopaedic Trauma: Fracture Mechanics, Classification & Healing

6.1 Fracture Mechanics, Morphology & AO/OTA Classification Principles 6.2 Open Fracture Management & Gustilo-Anderson Classification Protocol 6.3 Biology of Bone Healing, Physis (Salter-Harris) Injuries & Healing Complications

7 Chapter 7: Orthopaedic Emergencies & Trauma Complications

7.1 Acute Compartment Syndrome: Pathophysiology, The 6 Ps, Pressure Monitoring & Fasciotomy 7.2 Fat Embolism Syndrome (FES): Pathophysiology, Triad Recognition & Supportive Care 7.3 Hemorrhagic Shock, Pelvic Ring Disruptions & Damage Control Orthopaedics 7.4 Traumatic Spinal Cord Injury (SCI), Spinal/Neurogenic Shock & Autonomic Dysreflexia

8 Chapter 8: Upper Extremity, Lower Extremity & Pelvic Trauma Nursing Care

8.1 Proximal Femur & Hip Fractures: Femoral Neck, Intertrochanteric & Subtrochanteric Fixation 8.2 Diaphyseal & Articular Fractures of the Lower Extremity (Femur, Tibia, Ankle & Foot) 8.3 Upper Extremity Fractures, Dislocation Management & Peripheral Nerve Injuries

9 Chapter 9: Casts, Splints, Traction & External Fixation

9.1 Plaster & Synthetic Casting: Application, Cast Care, Windowing & Bivalving 9.2 Skin & Skeletal Traction: Buck's, Russell's, Balanced Suspension & Skeletal Traction Protocols 9.3 External Fixation, Ring Fixators, Pin Site Care Protocols & Infection Surveillance

10 Chapter 10: Sports Injuries: Ligamentous, Meniscal & Soft-Tissue Pathologies

10.1 Knee Ligamentous Injuries: ACL, PCL, MCL & LCL Pathophysiology, Special Tests & Reconstruction 10.2 Meniscal Pathologies: Vascular Zones, Tear Patterns, Meniscectomy vs. Meniscal Repair 10.3 Shoulder Instability, Labral Lesions (SLAP/Bankart) & Rotator Cuff Disorders 10.4 Tendinopathies, Overuse Syndromes, Concussion Protocol & Return-to-Play Criteria

11 Chapter 11: Metabolic Bone Disorders & Fragility Fractures

11.1 Osteoporosis & Osteopenia: Bone Remodeling, Risk Factors & DEXA Diagnostics 11.2 Pharmacotherapy: Bisphosphonates, Denosumab, Anabolic Agents & Patient Education 11.3 Osteomalacia, Rickets & Paget's Disease of Bone (Osteitis Deformans) 11.4 Vertebral Compression Fractures: Pathogenesis, Bracing, Vertebroplasty & Kyphoplasty

12 Chapter 12: Inflammatory Musculoskeletal Disorders & Infectious Conditions

12.1 Rheumatoid Arthritis: Autoimmune Pathophysiology, Manifestations & DMARD / Biologic Therapies 12.2 Ankylosing Spondylitis, Psoriatic Arthritis, Gout & Pseudogout (CPPD) 12.3 Septic Arthritis: Microorganisms, Arthrocentesis Findings, Emergency Debridement & Nursing Care 12.4 Osteomyelitis: Acute vs. Chronic, Biofilm Dynamics, Surgical Debridement & Long-Term Antibiotic Care

13 Chapter 13: Congenital, Pediatric & Musculoskeletal Oncologic Conditions

13.1 Developmental Dysplasia of the Hip (DDH), Clubfoot (Talipes Equinovarus) & Pediatric Hip Disorders 13.2 Pediatric & Adolescent Spinal Deformities: Idiopathic Scoliosis, Kyphosis & Bracing / Surgery 13.3 Musculoskeletal Oncology: Benign Bone Tumors, Primary Malignancies & Metastatic Bone Disease

14 Chapter 14: Neuromuscular Syndromes, Pain Modalities & Rehabilitation Competencies

14.1 Peripheral Nerve Compression Neuropathies (CTS, Cubital Tunnel, Tarsal Tunnel) & Complex Regional Pain Syndrome 14.2 Multimodal Pharmacologic Analgesia, Regional Nerve Blocks, PCA Management & Opioid Stewardship 14.3 Progressive Ambulation, Assistive Device Prescriptions, Crutch Gaits, DVT Prophylaxis & Discharge Planning

4.3 Revision Arthroplasty, Aseptic Loosening, Osteolysis & Implant Failure

Key Takeaways Explain This Topic AI

Aseptic loosening is driven by macrophage phagocytosis of submicron polyethylene and metal wear debris, triggering an inflammatory cascade (TNF-α, IL-1β, IL-6, RANKL) that drives osteoclastic bone resorption.

Trunnionosis and Mechanically Assisted Crevice Corrosion (MACC) at modular head-neck junctions produce toxic cobalt/chromium debris, local pseudotumors, and abductor necrosis, requiring serum metal ion testing and MARS-MRI.

Periprosthetic fractures are categorized by validated classification systems (Vancouver for THA, Lewis-Rorabeck for TKA), where stem stability and bone stock determine internal fixation versus revision with long fluted diaphyseal stems.

Evaluation of the painful arthroplasty mandates systematic exclusion of Periprosthetic Joint Infection (PJI) via ESR, CRP, and diagnostic arthrocentesis (synovial WBC, PMN%, and 14-day cultures for Cutibacterium acnes) before any revision.

Last updated: August 2026

Cellular Pathophysiology of Wear Debris, Osteolysis, and Aseptic Loosening

Aseptic loosening remains the leading long-term etiology of mechanical total joint failure. It is the end-stage clinical result of a biological, particle-induced osteolytic cascade triggered by microscopic wear debris generated at articulating and modular interfaces. PARTICLE-INDUCED OSTEOLYSIS CASCADE

  • [Articular Wear / Tribology] (UHMWPE, Metal, PMMA Debris)
  • |
  • v (Generation of submicron particles: 0.1-1.0 µm)
  • [Macrophage Phagocytosis] (Frustrated phagocytosis / activation)
  • |
  • v (Release of pro-inflammatory cytokines)
  • [Pro-Inflammatory Cascade] (TNF-α, IL-1β, IL-6, PGE2, RANKL)
  • |
  • v (Stimulates osteoclast differentiation & suppresses osteoblasts)
  • [Osteoclast-Mediated Bone Resorption] (Periprosthetic Osteolysis)
  • |
  • v (Interface fibrous membrane formation & progressive debonding)
  • [Aseptic Loosening & Mechanical Implant Subsidence]
  • The Particle-Induced Osteolytic Cascade

Generation of Submicron Particulate Debris: Normal joint articulation and micro-motion generate billions of submicron (0.1 to 1.0 µm) wear particles per year from ultra-high-molecular-weight polyethylene (UHMWPE), cobalt-chromium alloys, titanium, and polymethylmethacrylate (PMMA) cement mantles.

Macrophage Phagocytosis: Resident peri-prosthetic tissue macrophages engulf these foreign particles. Because macrophages lack enzymatic pathways to degrade synthetic polymers and metals, they undergo "frustrated phagocytosis" and cellular stress activation.

Pro-Inflammatory Cytokine Secretion: Activated macrophages release potent inflammatory mediators into the effective joint space, including Tumor Necrosis Factor-alpha (TNF-α) , Interleukin-1 beta (IL-1β) , Interleukin-6 (IL-6) , Prostaglandin E2 (PGE2) , and Receptor Activator of Nuclear Factor-κB Ligand (RANKL) .

Osteoclast Recruitment and Bone Resorption: RANKL binds to RANK receptors on osteoclast precursors, driving aggressive osteoclastogenesis and bone resorption at the bone-implant interface. Simultaneously, pro-inflammatory cytokines suppress osteoblastic bone formation.

Debonding and Loosening: Progressive periprosthetic bone loss leads to radiolucent lines (>2 mm), expansive osteolytic cysts, destruction of supporting trabeculae, fibrous membrane interposition, and gross mechanical loosening with implant subsidence or migration.